{"date":"2025-04-02","count":19,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6973-2025-04-02-2139-1kyzcwh","company_id":"6973","company":"永立榮","market":"興櫃","industry":"生技醫療","date":"2025-04-02","time":"21:39:11","subject":"本公司新藥UA002治療男性勃起功能障礙臨床一期收案完成，即將進入臨床二期(Ph2a)","clause":"第8款","fact_date":"2025-04-02","cite_as":"公開資訊觀測站重大訊息：永立榮（6973），2025-04-02 21:39，「本公司新藥UA002治療男性勃起功能障礙臨床一期收案完成，即將進入臨床二期(Ph2a)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-04-02-1910-1ut36ee","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-04-02","time":"19:10:10","subject":"公告本公司FB825應用於治療IgE介導的過敏性疾病之專利取得墨西哥專利證書","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-04-02 19:10，「公告本公司FB825應用於治療IgE介導的過敏性疾病之專利取得墨西哥專利證書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2025-04-02-1740-1lccp82","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2025-04-02","time":"17:40:58","subject":"公告本公司財務主管異動案(補充公告113年10月7日財務長留職停薪情形)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2025-04-02 17:40，「公告本公司財務主管異動案(補充公告113年10月7日財務長留職停薪情形)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-04-02-1734-pj3dmz","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-04-02","time":"17:34:55","subject":"公告更正本公司2024年合併財務報告附註附表二","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-04-02 17:34，「公告更正本公司2024年合併財務報告附註附表二」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2025-04-02-1703-bwopfv","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2025-04-02","time":"17:03:01","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2025-04-02 17:03，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2025-04-02-1659-4isxpt","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2025-04-02","time":"16:59:50","subject":"公告本公司董事會通過會計主管任命案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2025-04-02 16:59，「公告本公司董事會通過會計主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2025-04-02-1658-1dz66o3","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2025-04-02","time":"16:58:55","subject":"公告本公司董事會決議召開股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2025-04-02 16:58，「公告本公司董事會決議召開股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2025-04-02-1657-1dmdgdo","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2025-04-02","time":"16:57:58","subject":"公告本公司董事會通過113年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2025-04-02 16:57，「公告本公司董事會通過113年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-04-02-1644-12bxe3b","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-04-02","time":"16:44:14","subject":"公告本公司113年度財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-04-02 16:44，「公告本公司113年度財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2025-04-02-1642-5l4r38","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2025-04-02","time":"16:42:20","subject":"公告本公司國內第三次無擔保轉換公司債代收價款合約及存儲專戶合約","clause":"第51款","fact_date":"2025-04-02","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2025-04-02 16:42，「公告本公司國內第三次無擔保轉換公司債代收價款合約及存儲專戶合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-04-02-1628-o9jske","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-04-02","time":"16:28:20","subject":"公告本公司申請股票上巿時所出具之承諾事項暨其後續執行情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-04-02 16:28，「公告本公司申請股票上巿時所出具之承諾事項暨其後續執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2025-04-02-1559-18g4v0k","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2025-04-02","time":"15:59:23","subject":"更正本公司113年個體及合併財務報告附註揭露內容","clause":"第51款","fact_date":"2025-04-02","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2025-04-02 15:59，「更正本公司113年個體及合併財務報告附註揭露內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-04-02-1545-jrba43","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-04-02","time":"15:45:38","subject":"本公司董事會決議召開114年股東常會(調整股東常會日期與召開方式)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-04-02 15:45，「本公司董事會決議召開114年股東常會(調整股東常會日期與召開方式)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2025-04-02-1541-v6ipw6","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2025-04-02","time":"15:41:52","subject":"公告本公司第一次買回庫藏股已執行完畢情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2025-04-02 15:41，「公告本公司第一次買回庫藏股已執行完畢情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2025-04-02-1535-1kwo8q6","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2025-04-02","time":"15:35:44","subject":"代子公司「江蘇生達生技醫藥有限公司」公告資金貸與超限改善計畫","clause":"第51款","fact_date":"2025-04-02","cite_as":"公開資訊觀測站重大訊息：生達（1720），2025-04-02 15:35，「代子公司「江蘇生達生技醫藥有限公司」公告資金貸與超限改善計畫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2025-04-02-1435-11gu09k","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2025-04-02","time":"14:35:53","subject":"公告本公司已完成新藥Silmitasertib(CX-4945)治療基底細胞癌1期/劑量延伸(Expansion)人體臨床試驗數據分析結果。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2025-04-02 14:35，「公告本公司已完成新藥Silmitasertib(CX-4945)治療基底細胞癌1期/劑量延伸(Expansion)人體臨」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2025-04-02-1432-1cyn967","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2025-04-02","time":"14:32:10","subject":"公告本公司財務主管及會計主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2025-04-02 14:32，「公告本公司財務主管及會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-04-02-0600-16x1y29","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-04-02","time":"06:00:40","subject":"公告本公司董事會決議召開民國114年股東常會(新增議案及修改提名期間)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-04-02 06:00，「公告本公司董事會決議召開民國114年股東常會(新增議案及修改提名期間)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-04-02-0600-19mrd7","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-04-02","time":"06:00:17","subject":"更正本公司資金貸與資訊揭露明細表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-04-02 06:00，「更正本公司資金貸與資訊揭露明細表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}